Liver Diseases  >>  Victoza (liraglutide)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Victoza (liraglutide) / Novo Nordisk
MAGNA VICTORIA, NCT01761318: Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients

Completed
4
50
Europe
Liraglutide, Trade name: Victoza, EV Product Code: SUB25238, Name of the Marketing Authorisation Holder: Novo Nordisk, Marketing Authorisation number: EU/1/09/529/001, ATC code: A10BX07, CAS number 204656-20-2, Liraglutide - Placebo, Placebo
Leiden University Medical Center, Novo Nordisk A/S
Diabetes Mellitus Type 2, Metabolic Syndrome, Cardiovascular Disease, Diastolic Dysfunction, Fatty Liver
03/16
03/16

Download Options